WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

The Journal of Neuroscience, August 6, 2003, 23(18):7069-7074

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (59)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gryder, D. S.
Right arrow Articles by Rogawski, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gryder, D. S.
Right arrow Articles by Rogawski, M. A.

 Previous Article  |  Next Article 

BRIEF COMMUNICATION
Selective Antagonism of GluR5 Kainate-Receptor-Mediated Synaptic Currents by Topiramate in Rat Basolateral Amygdala Neurons

Divina S. Gryder and Michael A. Rogawski

Epilepsy Research Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20892-4457

Topiramate is a widely used antiepileptic agent whose mechanism of action is poorly understood. The drug has been reported to interact with various ion channel types, including AMPA/kainate receptors. In whole-cell voltage-clamp recordings from principal neurons of the rat basolateral amygdala, topiramate at low concentrations (IC50, ~0.5 µM) selectively inhibited pharmacologically isolated excitatory synaptic currents mediated by kainate receptors containing the GluR5 subunit. Topiramate also partially depressed predominantly AMPA-receptor-mediated EPSCs, but with lower efficacy. Topiramate did not alter the degree of facilitation in paired-pulse experiments, and it reduced the amplitude of miniature EPSCs without affecting their frequency, demonstrating that the block of synaptic responses occurs postsynaptically. Inhibition of GluR5 kainate receptors could represent a key mechanism underlying the anticonvulsant activity of topiramate. Moreover, these results support the concept that GluR5 kainate receptors represent a novel target for antiepileptic drug development.

Key words: topiramate; kainate receptor; AMPA receptor; amygdala; synaptic current; patch-clamp recording


Received Mar. 4, 2003; revised Jun. 9, 2003; accepted Jun. 17, 2003.




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
M. F. M. Braga, V. Aroniadou-Anderjaska, H. Li, and M. A. Rogawski
Topiramate Reduces Excitability in the Basolateral Amygdala by Selectively Inhibiting GluK1 (GluR5) Kainate Receptors on Interneurons and Positively Modulating GABAA Receptors on Principal Neurons
J. Pharmacol. Exp. Ther., August 1, 2009; 330(2): 558 - 566.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
M. A. Rogawski
Common Pathophysiologic Mechanisms in Migraine and Epilepsy
Arch Neurol, June 1, 2008; 65(6): 709 - 714.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
M. F. Ireland, F. C. Lenal, A. R. Lorier, D. E. Loomes, T. Adachi, T. S. Alvares, J. J. Greer, and G. D. Funk
Distinct receptors underlie glutamatergic signalling in inspiratory rhythm-generating networks and motor output pathways in neonatal rat
J. Physiol., May 1, 2008; 586(9): 2357 - 2370.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
M. Schubert, C. Drephal, and D. Albrecht
Gender-dependent ATPA-induced changes in long-term potentiation in the rat lateral amygdala
FASEB J, April 1, 2008; 22(4): 1268 - 1274.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
S. Remy and H. Beck
Molecular and cellular mechanisms of pharmacoresistance in epilepsy
Brain, January 1, 2006; 129(1): 18 - 35.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
P. L. Follett, W. Deng, W. Dai, D. M. Talos, L. J. Massillon, P. A. Rosenberg, J. J. Volpe, and F. E. Jensen
Glutamate Receptor-Mediated Oligodendrocyte Toxicity in Periventricular Leukomalacia: A Protective Role for Topiramate
J. Neurosci., May 5, 2004; 24(18): 4412 - 4420.
[Abstract] [Full Text] [PDF]



-
-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2009 by Society for Neuroscience ONLINE ISSN: 1529-2401
-